Surgery Partners, Inc. (SGRY) Gets Required Noteholder Consents for Merger-Related Changes
Surgery Partners' subsidiary secured noteholder consents to amend its $1.225B 7.250% notes due 2032. Changes will take effect before the merger, with consenting holders receiving $5 per $1,000 of notes in 2026. The merger still requires stockholder and regulatory approvals.
How this was made

The 30-second read
Why it matters
By securing noteholder consents, Surgery Partners removes a financing and covenant-related gating item for merger-related changes, improving execution credibility while keeping the outcome conditional.
Market read
Traders may reassess merger-closing probability modestly, but should still wait for stockholder and regulatory approvals and satisfaction of closing conditions.
What to watch
Deal timing risk remains high until approvals and closing conditions are satisfied; noteholder consent does not eliminate potential last-mile deal friction.
Background
The company previously announced a merger agreement; this update concerns required consents to amend an indenture for its 2032 notes.
Ticker impact
Surgery Partners says its subsidiary obtained required noteholder consents to amend $1.225B of 7.250% notes, enabling merger-related changes before closing.
Likely modest support for the stock as the market prices improved probability of merger closing, with upside capped until approvals and closing conditions are satisfied.
The article is a specific execution step tied to merger-related indenture amendments, but it explicitly states amendments become operative immediately before the merger if consummated, not that the merger has closed.
Market effects
Limited read-through to the healthcare services sector; this is primarily company-specific capital-structure execution for a merger.
No clear regional spillover indicated by the article.
Minimal global relevance; the news is a US-listed issuer’s debt-consent step tied to a domestic merger.
Counterpoint
Because the amendments are only operative immediately before the merger if consummated, the market may treat this as incremental and keep focus on regulatory and stockholder approvals.
Key entities
- public_companySurgery Partners, Inc.
Subject of the article; obtained required noteholder consents for merger-related indenture amendments.
- debt_instrument7.250% notes due 2032
$1,225.0M notes whose indenture amendments require noteholder consents.